Business Context and Reporting Period
Company: Ingevity Corp (NGVT)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended March 31, 2026
Business Overview: Ingevity provides products and technologies for purification, protection, and enhancement across automotive, food, water, and chemical filtration sectors. The company operates three reportable segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.
Key Financial Metrics
| Metric (in millions) | Q1 2026 | Q1 2025 |
|---|---|---|
| Net Sales | $258.0 | $247.9 |
| Gross Profit | $116.4 | $111.9 |
| Net Income (Continuing Ops) | $23.4 | $29.1 |
| Net Income (Total) | $59.8 | $20.5 |
| Diluted EPS (Total) | $1.66 | $0.56 |
| Operating Cash Flow | $(2.0) | $25.4 |
| Free Cash Flow (approx.) | $(12.3) | $15.4 |
| Total Debt (incl. leases) | $1,207.1 | $1,211.6 |
| Cash & Equivalents | $95.4 | $71.5 |
Note: Total Net Income includes a $36.4 million gain from discontinued operations (sale of Industrial Specialties). Continuing operations Net Income decreased due to litigation charges and other non-recurring items.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 4% ($10.1 million) driven by favorable pricing/mix ($6.5M) and foreign exchange ($3.2M), offsetting flat volume.
- Discontinued Operations: The company completed the sale of its Industrial Specialties product line and CTO Refinery on January 1, 2026, recognizing a $55.6 million gain. This resulted in a significant swing in total Net Income compared to Q1 2025, which included a loss from these operations.
- Continuing Operations Profitability: Net income from continuing operations declined 20% ($5.7 million) year-over-year. This was primarily due to a $16.2 million litigation charge related to the BASF settlement, a $2.8 million license impairment, and $3.2 million in portfolio realignment costs.
- Cash Flow: Operating cash flow turned negative ($2.0M outflow) compared to a $25.4M inflow in the prior year, driven by a $33.9 million increase in working capital (receivables and inventory) and the non-cash nature of the discontinued operations gain.
- Segment Performance:
- Performance Materials: Sales up 6%; EBITDA up 10% to $92.0M.
- Performance Chemicals: Sales flat; EBITDA dropped to $0.6M (from $5.8M) due to lower plant utilization in the Road Markings line.
- Advanced Polymer Technologies: Sales up 5%; EBITDA declined to $7.6M (from $13.6M) due to higher manufacturing costs and unfavorable mix.
Guidance, Outlook, and Risks
Full Year 2026 Outlook
- Net Sales: Expected between $1.05 billion and $1.15 billion.
- Adjusted EBITDA: Expected between $370 million and $395 million.
- Effective Tax Rate: Expected between 22% and 24%.
- Capital Expenditures: Projected at $40 million to $60 million.
Management Commentary: The outlook excludes the divested Industrial Specialties and Road Markings product lines (sold April 15, 2026). Management anticipates low-single-digit growth in Performance Materials and Advanced Polymer Technologies, and mid-single-digit growth in Performance Chemicals (excluding divestitures). The company expects to eliminate at least $15 million of indirect costs associated with the divestitures in 2026.
Risks and Contingencies
- Legal Settlement: A $113.2 million settlement with BASF (judgment + fees) was accrued and paid in April 2026. The $16.2 million legal fee portion was expensed in Q1 2026.
- Divestitures: The company is managing the transition of the Road Markings product line (sold to PPG Industries) and the Industrial Specialties line, which will result in temporary indirect cost burdens.
- Market Risks: Exposure to foreign currency fluctuations (Euro, Brazilian Real, Chinese Renminbi) and commodity price volatility (natural gas).
Investor Verification Checklist
- Discontinued Operations Impact: Verify the sustainability of earnings by excluding the $36.4 million gain from the sale of Industrial Specialties; focus on the $23.4 million continuing operations net income.
- Litigation Resolution: Confirm the full $113.2 million BASF settlement liability has been settled and assess any remaining legal contingencies.
- Working Capital Trends: Investigate the $33.9 million increase in working capital usage, specifically the rise in accounts receivable and inventory levels.
- Segment Margins: Monitor the significant compression in Performance Chemicals EBITDA margin (down to 1.0%) and Advanced Polymer Technologies margin (down to 17.2%) to ensure recovery in subsequent quarters.
- Debt Covenants: Verify compliance with the revolving credit facility covenants (Net Leverage 2.5x, Interest Coverage 6.2x) following the recent amendment reducing facility size to $750 million.